Robert F. Kennedy Jr., Donald Trump’s pick to lead the US Department of Health and Human Services, has been vocally anti-pharma. Pharma, Congress, and the courts, though, all get a say.
The company said that Buddy Chester Sub LLC, an entity affiliated with funds advised by top investor BC Partners Advisors LP, was putting up a public offering valued at $500 million. In addition, the ...